Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly for targeting tyrosine kinases involved in cancer cell proliferation. Shows potential in developing treatments for chronic myeloid leukemia and other malignancies. Also employed in the design of anti-inflammatory agents due to its ability to modulate signaling pathways linked to immune response. Its structure supports binding to ATP sites in enzymes, making it valuable in creating selective inhibitors. Investigated for use in PET imaging probes due to favorable binding and clearance properties.